T. Rowe Price Health Sciences (PRHSX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
79.38
+0.20 (0.25%)
Aug 29, 2025, 4:00 PM EDT
0.25% (1Y)
| Fund Assets | 10.82B |
| Expense Ratio | 0.80% |
| Min. Investment | $500,000 |
| Turnover | 52.40% |
| Dividend (ttm) | 10.25 |
| Dividend Yield | 12.83% |
| Dividend Growth | 123.89% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 16, 2024 |
| Previous Close | 79.18 |
| YTD Return | -0.44% |
| 1-Year Return | -12.38% |
| 5-Year Return | 21.84% |
| 52-Week Low | 71.94 |
| 52-Week High | 102.48 |
| Beta (5Y) | 0.68 |
| Holdings | 235 |
| Inception Date | Dec 29, 1995 |
About PRHSX
The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.
Fund Family T. Rowe Price
Category Health
Stock Exchange NASDAQ
Ticker Symbol PRHSX
Index S&P 500 TR
Performance
PRHSX had a total return of -12.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.61%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| THISX | T. Rowe Price Health Sciences Fund-i Class | 0.67% |
Top 10 Holdings
47.76% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.93% |
| Intuitive Surgical, Inc. | ISRG | 5.81% |
| UnitedHealth Group Incorporated | UNH | 5.08% |
| Stryker Corporation | SYK | 4.98% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.84% |
| Boston Scientific Corporation | BSX | 3.69% |
| argenx SE | ARGX | 3.33% |
| Danaher Corporation | DHR | 3.10% |
| Thermo Fisher Scientific Inc. | TMO | 3.07% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.93% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2024 | $10.2497 | Dec 17, 2024 |
| Dec 15, 2023 | $4.578 | Dec 18, 2023 |
| Dec 15, 2022 | $1.5867 | Dec 16, 2022 |
| Dec 15, 2020 | $0.930 | Dec 16, 2020 |
| Dec 16, 2019 | $5.030 | Dec 17, 2019 |
| Dec 14, 2018 | $4.400 | Dec 17, 2018 |